NASDAQ PRESS RELEASE:
Thursday July 16, 5:11 pm Eastern Time
Company Press Release
SOURCE: MedCare Technologies, Inc.
MedCare to List on NASDAQ Small Cap
OAK BROOK, Ill., July 16 /PRNewswire/ -- MedCare Technologies, Inc. today announced the approval of its listing on the NASDAQ Small Cap market. Effective
July 20th, the Company's shares shall trade on the Small Cap market under stock symbol, MCAR.
''I'm extremely pleased with MedCare's Small Cap listing approval,'' said Jeff Aronin, President of MedCare Technologies. ''This listing will provide our
Company dramatically enhanced exposure to individual investors, brokers and institutions. As such, we expect greater interest from the investment community
and look forward to the added visibility this listing will immediately offer.''
The MedCare Program Does Not Require FDA Approval and is Risk Free
MedCare Technologies has developed a cost effective, non-drug, non-surgical and non-invasive system for the care and treatment of patients suffering from
urinary incontinence. MedCare's proprietary treatment protocol does not require FDA approval, is covered by most health insurance plans and results in the
reduction complete elimination of the most commonly found urinary incontinence symptoms. Unlike traditional treatment options, which are costly and often
unsuccessful or inadequate, MedCare's treatment program is completely risk free and has a proven success rate in excess of 85% using a multi-modality
program based on behavioral techniques and neuromuscular electromyography biofeedback. Affecting some 25 million Americans, UI is a $20 billion market
and accounts for almost half of all nursing home admissions. Despite being one of the most prevalent medical conditions in health care today with almost half of
all women being affected at some point, UI remains a vastly under-serviced and over-looked market place.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include
statements, concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are other
than statements of historical facts. These statements are subject to changes in technology, changes in insurance reimbursement, economic conditions, the impact
of competition and pricing, government regulation, and other risks defined in this document and in statements filed from time to time with the Securities and
Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company are expressly qualified
by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims
any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, contact Mr. Bill Mann at 800-611-3388.
SOURCE: MedCare Technologies, Inc. |
